Veeva Systems Surges to 164th in Market Activity with $514 Million Trading Volume Despite 1.50% Stock Decline

On May 28, 2025, Veeva Systems (VEEV) closed with a trading volume of $514 million, marking a 64.11% increase from the previous day and ranking 164th in the day's market activity. However, the stock price decreased by 1.50%.

Veeva Systems reported its fiscal 2026 first quarter results, with total revenues reaching $759.0 million, a 17% increase from the same period last year. The company's earnings per share (EPS) were $1.97, surpassing the forecasted $1.74. Revenue also exceeded expectations, reaching $759 million compared to the anticipated $728.32 million.

Subscription services revenues grew by 19% year-over-year to $634.8 million, contributing significantly to the overall revenue increase. The company's strong performance was driven by its robust product portfolio and strategic deals. Veeva Systems continues to drive the migration to its next-gen Vault CRM, with 20 new customers adopting the solution in the fourth quarter. The company expects most top 20 pharma firms to make migration decisions by fiscal 2026.

Veeva Systems has introduced AI-driven innovations such as CRM Voice Control, CRM Bot, and MLR Bot to enhance efficiency, compliance, and automation. Its Clinical Development Cloud sees growing adoption, with 17 of the top 20 pharma companies using its CTMS and a ninth committing to its EDC solution. Investments in RTSM and eCOA further expand its market opportunities.

Veeva Systems' Data Cloud solutions, including Compass, OpenData, Link, and the new Pulse, are gaining momentum. Compass supports over 100 brands, and Pulse secured its first seven-figure deal to enhance pharma segmentation and targeting. The company is also expanding its Safety suite, offering a fully cloud-based solution for signal detection, adverse event reporting, and regulatory compliance, with automated updates and seamless clinical integration.

Strategic deals, such as Boehringer Ingelheim's commitment to migrate to Veeva Vault CRM and ACTO joining the Veeva AI Partner Program, further solidify Veeva Systems' position in the market. Additionally, the long-term partnership with Walgreens Boots Alliance aims to improve patient outcomes by connecting community locations with diverse patient populations for easier clinical research access.